Stockreport

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

Vincerx Pharma, Inc.  (VINC) 
PDF PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of pa [Read more]